Dudediligence.

Repligen Corporation

RGENNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Acquisition or sale of assetsOct 6 →InsidersNo open-market buys. 4 insiders sold $9.1M, 7 of 16 sales on a 10b5-1 plan.→HoldersBlackRock 9.5%FMR 5.9%United Capital Financial 4.9%→PeersClosest companies: TECH, LAB, RVTY→

From the filings

Figures

Revenue
$785.1Mlast 12 months
Net income
$41.5Mlast 12 months
Operating cash flow
$130.7Mlast 12 months
Cash and equivalents
$606.8Mat the last balance sheet
Total debt
$551.0Mat the last balance sheet
Shares outstanding
56.4M shareson issue
Every year and quarter →